RAPH insider transaction filings

Raphael Pharmaceutical Inc. — 4 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-04-06. Screen RAPH transaction legs live →

FiledFormInsiderReported transactionsSource
2026-04-064Louria Hayon Igal — Chief Technology OfficerOption exercise/expiry (X): 350,000 @ $0.01 · Option exercise/expiry (X): 350,000 (derivative)EDGAR
2025-03-124Eliya Yehuda — DirectorGrant/award (A): 200,000 (derivative) @ $0 · Code (E): 202,000 (derivative) @ $0EDGAR
2025-03-114Pilo Shlomo — Chief Executive Officer, Director, 10% ownerGrant/award (A): 200,000 @ $0.50 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2025-03-064Dhadha Ajay Kumar — DirectorGrant/award (A): 350,000 @ $0 · Grant/award (A): 250,000 (derivative) @ $0EDGAR

Recent 8-K events — Raphael Pharmaceutical Inc.

FiledFormItems reportedSource
2026-07-178-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-03-248-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-08-118-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-08-118-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=RAPH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →